RE:Here's Why This Is Such a Great Buy Right NOW!!!Hotoffthepress wrote: 1. Trial completion news any day (end of June)
2. Trial results news early Q3 (July?)
3. Trial just needs to show safety, tolerabiity and pharmacodynamics. Blood levels need to be comparable to injection (does not need to show Efficacy)
4. Safety and tolerability already demonstrated in a previous trial
5. Company is "partnership discussions" in Europe, India, China and N. America for over 18 months
6. This may be our final trial?? (need confirmation) prior to FDA submission
7. We own the rights to Bertilimumba, going into Phase III in early 2019 with Immune
8. Immune owes us several million dollars (milestones) as soon as they start Phase III
9. Bertilimumab is Immunes lead drug so they must press for Phase III
10. We are expecting PK/PD data on Beriliumamb in Q3
11. Immune meeting FDA in Q3 to discuss Phase III so expect a PR
12. We have an AGM meeting next week in Vancouver on June 27th at 10:00am